BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2021 7:56:20 AM | Browse: 443 | Download: 1214
 |
Received |
|
2021-01-28 01:06 |
|
Peer-Review Started |
|
2021-01-28 01:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-07 00:49 |
|
Revised |
|
2021-03-18 17:54 |
|
Second Decision |
|
2021-04-26 10:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-26 11:41 |
|
Articles in Press |
|
2021-04-26 11:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-07-27 07:00 |
|
Publish the Manuscript Online |
|
2021-08-04 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry and Rosane Harter Griep |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0010.00 RS |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0300.00 ES |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0212.00 BA |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0278.00 MG |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0115.00 SP |
| Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) |
01 06 0071.00 RJ |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and the Carlos Chagas Filho Rio de Janeiro State Research Support Foundation (FAPERJ) |
|
|
| Corresponding Author |
Anissa Daliry, MSc, PhD, Academic Research, Laboratory of Cardiovascular Investigation, Oswaldo Cruz Foundation, Manguinhos, Rio de Janeiro 21040-360, Brazil. daliry@ioc.fiocruz.br |
| Key Words |
Advanced glycation end products; Non-alcoholic fatty liver disease; Steatosis; ELSA-Brasil study; Spectroscopy |
| Core Tip |
We evaluated the relationship between fluorescent advanced glycation end product (AGE) levels and the severity of non-alcoholic fatty liver disease (NAFLD)-associated steatosis. We evaluated 305 subjects with NAFLD from Rio de Janeiro in the baseline ELSA-Brasil population grouped according to the steatosis stratification: mild and moderate/severe pooled. Serum AGE levels were correlated with the steatosis grade in the overall sample. The severity of NAFLD-associated steatosis was associated with serum AGE levels; therefore, plasmatic fluorescent AGE quantification by spectroscopy could be a promising alternative method for classifying and grading NAFLD accordingly to hepatic steatosis. |
| Publish Date |
2021-08-04 07:56 |
| Citation |
Pereira ENGDS, Paula DP, Araujo BP, Fonseca MJMD, Diniz MFHS, Daliry A, Griep RH. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World J Gastroenterol 2021; 27(29): 4913-4928 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i29/4913.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i29.4913 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
